Antilymphocytic Serum--the Possible Clinical Applications

Overview

Journal Proc R Soc Med

Specialty General Medicine

Date 1970 Sep 1

PMID 4920442

Authors

M H Lessof

Affiliations

Soon will be listed here.

References

Waksman B, ARBOUYS S, Arnason B . The use of specific "lymphocyte" antisera to inhibit hypersensitive reactions of the "delayed" type. J Exp Med. 1961; 114:997-1022. PMC: 2180405. DOI: 10.1084/jem.114.6.997. View

Currey H, ZIFF M . Suppression of experimentally induced polyarthritis in the rat by heterologous anti-lymphocyte serum. Lancet. 1966; 2(7469):889-91. DOI: 10.1016/s0140-6736(66)91984-2. View

Lance E, Medawar P . Immunosuppressive effects of heterologous antilymphocyte serum in monkeys. Lancet. 1970; 1(7639):167-70. DOI: 10.1016/s0140-6736(70)90407-1. View

Kalden J, JAMES K, Williamson W, Irvine W . The effect of anti-lymphocytic IgG on estab- lished autoallergic thyroiditis in rats. Clin Exp Immunol. 1969; 5(6):597-606. PMC: 1579149. View

Leibowitz S, Lessof M, Kennedy L . The effect of anti-lymphocyte serum on experimental allergic encephalomyelitis in the guinea-pig. Clin Exp Immunol. 1968; 3(8):753-60. PMC: 1578971. View

Greaves M, Tursi A, Playfair J, Torrigiani G, Zamir R, Roitt I . Immunosuppressive potency and in-vitro activity of antilymphocyte globulin. Lancet. 1969; 1(7585):68-72. DOI: 10.1016/s0140-6736(69)91089-7. View

Brendel W, Land W, Hopf U, Seifert J . Induction of tolerance in man to horse-IgG. Lancet. 1969; 2(7630):1141-2. DOI: 10.1016/s0140-6736(69)90744-2. View

Levey R, Medawar P . Nature and mode of action of antilymphocytic antiserum. Proc Natl Acad Sci U S A. 1966; 56(4):1130-7. PMC: 220018. DOI: 10.1073/pnas.56.4.1130. View

TREPEL F, Pichlmayr R, Kimura J, Brendel W, BEGEMANN H . [Antilymphocyte serum therapy in human autoimmune diseases]. Klin Wochenschr. 1968; 46(16):856-64. DOI: 10.1007/BF01746244. View

10.

Butler W, Rossen R, Hersh E, DEBAKEY M, Diethrich E, BROOKS D . Prevention of rapid immune elimination of anti-lymphocytic globulin in transplant patients. Nature. 1969; 224(5222):856-60. DOI: 10.1038/224856a0. View

11.

Balner H, Dersjant H, van Bekkum D . Testing of antihuman lymphocyte sera in chimpanzees and lower primates. Transplantation. 1969; 8(3):281-90. DOI: 10.1097/00007890-196909000-00009. View

12.

DOAK P, Dalton N, Meredith J, Montgomerie J, North J . Use of antilymphocyte globulin after cadaveric renal transplantation. Br Med J. 1969; 4(5682):522-5. PMC: 1630331. DOI: 10.1136/bmj.4.5682.522. View

13.

Woodruff M, Anderson N . EFFECT OF LYMPHOCYTE DEPLETION BY THORACIC DUCT FISTULA AND ADMINISTRATION OF ANTILYMPHOCYTIC SERUM ON THE SURVIVAL OF SKIN HOMOGRAFTS IN RATS. Nature. 1963; 200:702. DOI: 10.1038/200702a0. View

14.

PIROFSKY B, Bardana Jr E, Bayracki C, Porter G . Antilymphocyte antisera in immunologically mediated renal disease. JAMA. 1969; 210(6):1059-64. View

15.

Bach J, Dormont J, Dardenne M, Balner H . In vitro rosette inhibition by antihuman antilymphocyte serum. Correlation with skin graft prolongation in subhuman primates. Transplantation. 1969; 8(3):265-80. DOI: 10.1097/00007890-196909000-00008. View